Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Henry Schein 3.458.
Gilead Sciences vs Henry Schein: Revenue Comparison
Gilead Sciences (GILD) and Henry Schein (HSIC) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $3.5B for Henry Schein. Gilead Sciences leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 31.8% for Henry Schein. Gilead Sciences's net margin is -134.5% versus 2.7% for Henry Schein.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Henry Schein.| Metric | Gilead Sciences | Henry Schein |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $3.46B |
| Cost of Revenue | $1.58B | $2.36B |
| Gross Profit | $6.22B | $1.10B |
| Operating Income | $-10.39B | $200.00M |
| Net Income | $-10.50B | $94.00M |
| R&D Expense | $1.76B | $0 |
| Earnings Per Share | -$8.45 | $0.82 |
| Gross Margin | 79.8% | 31.8% |
| Operating Margin | -133.2% | 5.8% |
| Net Profit Margin | -134.5% | 2.7% |
| Free Cash Flow | $3.69B | $196.00M |
| Cumulative Free Cash Flow | $155.83B | $9.89B |
| Operating Cash Flow | $3.57B | $242.00M |
| Cash & Equivalents | $3.18B | $157.00M |